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Abstract: Lipoprotein oxidation may play a
pivotal role in the pathogenesis of
atherosclerosis, and vitamin E and β–carotene
have been proposed to prevent the
development
and
progression
of
atherosclerosis.
The aim of this study was to investigate the
oxidative susceptibility of apolipoprotein B
(apo B)-containing lipoproteins and their
relation with vitamin E and total carotene
levels.
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The susceptibility of apo B-containing
lipoproteins
to
oxidation,
plasma
malondialdehyde (MDA), serum vitamin E,
total carotene, lipid and lipoprotein levels
were studied in 177 patients with coronary
artery disease (CAD) and 75 non-CAD
subjects. All subjects
(n = 252) had
undergone
coronary
catheterization.
Student’s unpaired t-test, chi-square test and

Introduction
There is increasing evidence that oxidation of low
density lipoprotein (LDL) plays a major role in the
pathogenesis of coronary artery disease (CAD). However,
results from some clinical studies on LDL oxidation and
CAD are not consistent and the pathway linking LDL to
CAD remains unclear. In addition to LDL, all
apolipoprotein B (apo B)-containing lipoproteins have
been considered atherogenic (1). The atherogenic
characteristics of oxidized apo B-containing lipoproteins
include accelerated uptake by macrophages, facilitation of
foam cell formation, chemoattraction for monocytes and
T lymphocytes and cytotoxicity to endothelial cells (2).
Antioxidants such as vitamin E and beta carotene can
prevent or delay atherogenesis by inhibiting the oxidation
of lipoproteins (3,4). Furthermore, antioxidants may
represent new preventive and therapeutic agents for CAD
(5). Some of the epidemiologic data show an inverse
correlation between CAD and vitamin E and total carotene

Pearson’s correlation test were used for the
statistical analyses.
CAD patients demonstrated significant
decreases in serum vitamin E and total
carotene levels and significant increases in low
density lipoprotein-cholesterol (LDL-C) and
MDA levels. ∆ MDA (oxidizability of apo Bcontaining lipoproteins) was negatively
correlated with vitamin E and inversely
correlated with LDL-C, apo B and MDA levels
in CAD patients.
In conclusion, oxidized forms of apo Bcontaining lipoproteins may play an important
role in the pathogenesis of atherosclerosis,
and antioxidant vitamin supplementation may
be useful in CAD by improving the oxidative
balance.
Key Words: Lipoprotein oxidation, Vitamin E,
Total carotene, Coronary artery disease

levels (6). On the other hand, several other studies found
no direct link between CAD and decreased levels of
antioxidant vitamins (7,8). Although many investigators
have worked on LDL oxidation, studies examining the
oxidation of apo B-containing lipoproteins are limited and
data from these studies are contradictory (9,10).
We, therefore, were interested in investigating the
susceptibility of apo B-containing lipoproteins to in vitro
oxidation in CAD patients.

Materials and Methods
One hundred and seventy-seven symptomatic CAD
patients (32 females and 145 males, age 36-73 years)
and 75 non-CAD subjects (45 females and 30 males, age
38-72 years), who had undergone coronary
catheterization (total 252) were included in this study.
Consent for coronary angiography and associated blood
tests were obtained from all patients. The disease group
included 21 patients with single-vessel, 41 patients with
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two-vessel, 115 patients with three-vessel CAD. By the
use of a questionnaire, histories of hypertension (treated
hypertension or untreated subjects with diastolic blood
pressure > 90 mmHg, systolic blood pressure > 140
mmHg in two measurements), diabetes mellitus, smoking
and family history of cardiovascular disease were
recorded. Family history was defined as positive if a
parent or sibling aged < 55 years had angina, had a
myocardial infarction or died unexpectedly. Height and
weight were measured and the body mass index (BMI)
was calculated. None of the subjects had been treated
with lipid lowering drugs.
Venous blood was drawn from the subjects after
overnight fasting and 4 mL of blood was transferred into
tubes containing EDTA (final concentration 4.08 mM),
and plasma was separated immediately. Lipoprotein
oxidation studies were performed within 24 hours. Blood
for measuring vitamin E and carotenoid was covered with
aluminium foil to protect it from light. Serum aliquots
separated for vitamin E, carotenoid and plasma aliquots
for malondialdehyde (MDA) were kept at -20 ºC and
assayed within two months, as suggested previously
(11,12).
Total cholesterol (TC) and triglyceride (TG) were
determined according to standard laboratory methods
using a Technicon-Dax 72 analyser (Technicon
Instruments Corporation, Tarrytown, NY, USA). High
density lipoprotein cholesterol (HDL-C) was quantified
after precipitation of apo B-containing lipoproteins with
dextran-sulphate and magnesium chloride (13). Apo A
and apo B were determined nephelometrically (Sanofi
Pasteur, Kallestad QM 300, France). LDL-C was
calculated according to the Friedewald equation (14).
Vitamin E was measured according to the principle that
tocopherols reduce ferric ions to ferrous ions and then
the latter form a red complex with α α`-dipyridyl (15).
Serum total carotene was measured by using
spectrophotometric method described by Neeld and
Pearson (16). Vitamin E and total carotene were assayed
in a dark room. Plasma malondialdehyde concentration
was determined using a colorimetric assay (17). In order
to determine the susceptibility of apo B-containing
lipoproteins (non-HDL fraction) to oxidation, this fraction
was separated by precipitation, and then the cholesterol
content of this fraction was adjusted to 200 µg/mL with
phosphate buffered saline (PBS). The non-HDL fraction
(0.5 mL) was oxidized in the presence of copper (final
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concentration 0.5 mM) in PBS at 37 ºC. The lipid
peroxide content of the oxidized non-HDL fraction was
determined by the thiobarbituric acid reacting substances
(TBARS) assay (18). TBARS was expressed as MDA
equivalents content using 1,1,3,3 tetraethoxypropane as
standard. MDA levels of the apo B-containing lipoproteins
were measured after 0, 30, 60, 90, 120, 150 and 180
minutes of incubation. ∆ MDA (oxidizability of apo Bcontaining lipoproteins) was recovered by taking the
difference between MDA levels of apo B-containing
lipoproteins at 180 and 0 minutes (19).
Data are expressed as mean ± SD. Student’s unpaired
t-test was used to determine the significance of difference
between means. Differences in prevalence were evaluated
by the chi-square test and differences were considered
significant when the probability was p< 0.05. Pearson’s
linear correlation was adopted for correlation analysis.

Results
Demographic characteristics of the groups are given in
Table 1. Table 2 shows the lipid profile (TC, TG, HDL-C,
LDL-C, apo AI and apo B), vitamin E, total carotene and
MDA levels. TC, TG, LDL-C, MDA and apo B levels were
significantly higher (p < 0.001 for each) while HDL-C,
apo AI, vitamin E and total carotene levels were
significantly lower (p < 0.001 for each) in the CAD
patients than those in non-CAD subjects (Table 2). MDA
levels of apo B-containing lipoproteins measured at time
intervals (except 0 minutes) and ∆ MDA were significantly
higher in the CAD group than in the non-CAD group
(Table 3).
Table 1.

Demographic Data of All the Subjects.
Non-CAD
(n = 75)

CAD
(n = 177)

51 ± 11

57 ± 10

Age (year)
Sex (Male/Female)
BMI (kg/m2)

30 / 45

145 / 32

25 ± 0.6

27 ± 0.4

Hypertension (%)

29

32

Smoking (%)

32

41

Diabetes (%)

11

12

Family history (%)

32

35

CAD = Coronary artery disease
BMI = Body mass index
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Table 2.

Lipid Profile, Antioxidants and Malondialdehyde Levels on
Subjects.

Parameters

Non-CAD
(n = 75)

CAD
(n = 177)

p values*

Total cholesterol (mmol/L)

5.05 ± 0.85

5.83 ± 1.09

< 0.001

Triglycerides (mmol/L)

1.66 ± 0.52

2.23 ± 0.78

< 0.001

HDL- cholesterol (mmol/L) 1.06 ± 0.18

0.85 ± 0.16

< 0.001

LDL-cholesterol (mmol/L)

3.21 ± 0.73

3.94 ± 0.85

< 0.001

Apo AI (g/L)

1.46 ± 0.24

1.31 ± 0.21

< 0.001

Apo B (g/L)

1.29 ± 0.33

1.42 ± 0.35

< 0.001

5.9 ± 1.8

8.2 ± 2.0

< 0.001

Total carotene (µmol/L)

3.11 ± 0.76

2.36 ± 0.65

< 0.001

Vitamin E (µmol/L)

35.0 ± 7.2

27.8 ± 8.1

< 0.001

Malondialdehyde (nmol/mL)

Data are expressed as mean ± SD.
* = Student’s unpaired t-test
CAD = Coronary artery disease

Table 3.

Malondialdehyde Levels* of Apolipoprotein B-Containing
Lipoproteins Measured at Time Intervals.

Time intervals
(min)
0

HDL = High density lipoprotein
LDL = Low density lipoprotein
Apo = Apolipoprotein

Non-CAD

6.75 ± 0.84

CAD

6.84 ± 0.75

p value

NS

30

7.61 ± 0.88

8.58 ± 1.16

< 0.01

60

12.01 ± 2.60

14.80 ± 4.56

< 0.001

90

31.36 ± 9.21

34.23 ± 7.85

< 0.02

120

43.97 ± 9.95

49.81 ± 11.05

< 0.02

150

55.30 ± 12.45

66.77 ± 13.47

< 0.0001

180

82.04 ± 18.10

98.30 ± 21.73

< 0.0001

∆ MDA

75.29 ± 18.39

91.46 ± 20.41

< 0.0001

* nmol/mg cholesterol
NS: Non-Significant

Correlations among ∆ MDA, vitamin E, total carotene,
MDA and serum lipid parameters were evaluated with
Pearson’s correlation coefficient. In CAD patients, ∆ MDA
was significantly positively correlated with LDL-C, apo B
and MDA levels and significantly inversely correlated with
vitamin E levels. MDA was significantly correlated with
LDL-C and apo B levels and significantly inversely
correlated with HDL-C, apo AI, vitamin E and total
carotene levels (Table 4). In non-CAD subjects, there was
a significant positive correlation between MDA and TC
levels. There was a significant negative correlation
between MDA and HDL-C levels (Table 4).

Discussion
The biologic modification of lipoproteins seems to play
an important role in the development of atherosclerosis
(20). Low, very-low density lipoproteins and lipoprotein
(a) are apo B-containing lipoproteins, and are susceptible
to oxidative modification. In vivo, the most likely process
responsible for this modification is lipid peroxidation, in
which the polyunsaturated fatty acids are rapidly
converted to lipid hydroperoxides and then to some
reactive aldehydes such as MDA, one of the most
frequently used indicators of lipid peroxidation (21,22).
Oxidized forms of apo B-containing lipoproteins are
similar in structure and play a role in atherogenesis (23).
In vitro, lipoproteins are subjected to oxidative stress by
adding micromolar amounts of copper and their
susceptibility to oxidation can be evaluated (24). The
oxidative susceptibility of lipoproteins has been shown to
correlate with the severity of coronary atherosclerosis
(25). In the present study, we found MDA levels of apo
B-containing lipoproteins at all time intervals and ∆ MDA
was significantly higher in patients with CAD than those
of subjects without CAD. Smoking is a well-established
risk factor for atherosclerosis and the proatherogenic
effects of smoking may be related to oxidative
modification of apo B-containing lipoproteins and
decrements in the levels of some antioxidants, such as βcarotene and vitamin E (26). The higher number of
smokers in the patient group may contribute to higher
levels of MDA in the plasma and apo B-containing
lipoprotein fraction of this group. Lipoproteins are
protected from oxidation by lipid-soluble antioxidants
such as α-tocopherol and β-carotene (27). α-tocopherol
is the most prevalent and biologically active form of
vitamin E and it traps peroxyl free radicals and thus acts
as a chain-breaking antioxidant (28). When vitamin E and
carotenoids are depleted from the lipoprotein particles,
they become more susceptible to oxidation (29,30).
Numerous human studies have shown that α-tocopherol
supplementation reduced LDL oxidizability and
progression of atherosclerosis in CAD patients (28,31). In
the present study we found that vitamin E levels were
significantly lower (p < 0.001) in patients with CAD and
there was a significantly negative correlation (p < 0.01)
between vitamin E and ∆ MDA. β-carotene is a member
of the carotenoid family of plant pigments that is also
carried in the blood within the LDL particle. Carotenoids
may protect low-density lipoprotein from oxidation, a
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Table 4.

Correlation of Plasma Malondialdehyde (MDA) and ∆ MDA with Lipid Parameters, Apolipoprotein AI, apolipoprotein B and Vitamin E and
Total Carotene.
CAD

non-CAD

Correlated parameters
∆ MDA

Plasma MDA

∆ MDA

Plasma MDA

Total Cholesterol

r = 0.07

p = NS

r = 0.09

p = NS

r = 0.27

p < 0.01

r = 0.16

p =NS

Triglycerides

r = 0.01

p = NS

r = 0.15

p = NS

r = 0.06

p = NS

r = 0.10

p = NS

HDL-Cholesterol

r = -0.20

p < 0.01

r = -0.03

p = NS

r = -0.22

p < 0.05

r = -0.08

p = NS

LDL-Cholesterol

r = 0.20

p < 0.01

r = 0.29

p < 0.001

r = 0.18

p = NS

r = 0.19

p = NS

Apolipoprotein AI

r = -0.18

p < 0.05

r = -0.06

p = NS

r = -0.15

p = NS

r = -0.19

p = NS

Apolipoprotein B

r = 0.17

p < 0.05

r = 0.28

p < 0.001

r = 0.19

p = NS

r = 0.05

p = NS

Vitamin E

r = -0.19

p <0.01

r = -0.21

p < 0.01

r = -0.11

p = NS

r = -0.19

p = NS

Total Carotene

r = -0.25

p < 0.001

r = -0.14

p = NS

r = -0.07

p = NS

r = -0.10

p = NS

CAD: Coronary Artery Disease, HDL: High Density Lipoprotein, LDL: Low Density Lipoprotein, NS: Non-Significant

process implicated in the development of atherosclerosis
(32). We found that total carotene levels were
significantly lower (p < 0.001) in patients with CAD.
Prospective epidemiologic studies have shown a strong
inverse correlation between HDL-C and CAD. In vitro,
HDL can partially protect LDL from oxidation mediated by
cells or by copper. Therefore, HDL could play an
important role in preventing or reducing the
atherosclerotic process by inhibiting LDL oxidation (33).
In this study, we observed a negative correlation between
HDL-C and plasma MDA in CAD patients.
In conclusion, we have shown that in CAD patients
plasma apo B-containing lipoproteins were more
++
susceptible to Cu -induced oxidation and also serum

vitamin E and total carotene levels were lower in patients
with CAD than those in non-CAD subjects. Therefore,
oxidized forms of apo B-containing lipoproteins may play
an important role in the pathogenesis of atherosclerosis,
and antioxidant vitamin supplementation may be useful in
CAD by improving the oxidative balance.
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